ALZN
Price
$3.06
Change
+$0.11 (+3.73%)
Updated
Jul 9 closing price
Capitalization
2.45M
AURX
Price
$1.54
Change
-$0.01 (-0.65%)
Updated
Jul 8 closing price
Capitalization
72.11M
Interact to see
Advertisement

ALZN vs AURX

Header iconALZN vs AURX Comparison
Open Charts ALZN vs AURXBanner chart's image
Alzamend Neuro
Price$3.06
Change+$0.11 (+3.73%)
Volume$180.73K
Capitalization2.45M
Nuo Therapeutics
Price$1.54
Change-$0.01 (-0.65%)
Volume$14.31K
Capitalization72.11M
ALZN vs AURX Comparison Chart in %
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALZN vs. AURX commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a StrongBuy and AURX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (ALZN: $3.06 vs. AURX: $1.54)
Brand notoriety: ALZN and AURX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 8% vs. AURX: 160%
Market capitalization -- ALZN: $2.45M vs. AURX: $72.11M
ALZN [@Biotechnology] is valued at $2.45M. AURX’s [@Biotechnology] market capitalization is $72.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 1 FA rating(s) are green whileAURX’s FA Score has 0 green FA rating(s).

  • ALZN’s FA Score: 1 green, 4 red.
  • AURX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALZN and AURX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 3 TA indicator(s) are bullish while AURX’s TA Score has 6 bullish TA indicator(s).

  • ALZN’s TA Score: 3 bullish, 2 bearish.
  • AURX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, AURX is a better buy in the short-term than ALZN.

Price Growth

ALZN (@Biotechnology) experienced а +2.00% price change this week, while AURX (@Biotechnology) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +12.58%. For the same industry, the average monthly price growth was +16.60%, and the average quarterly price growth was +18.46%.

Reported Earning Dates

ALZN is expected to report earnings on Mar 10, 2025.

Industries' Descriptions

@Biotechnology (+12.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AURX($72.1M) has a higher market cap than ALZN($2.45M). AURX YTD gains are higher at: 10.000 vs. ALZN (-70.690). AURX has higher annual earnings (EBITDA): -2.39M vs. ALZN (-4.16M). ALZN has more cash in the bank: 3.36M vs. AURX (55.7K). AURX has less debt than ALZN: AURX (148K) vs ALZN (301K). AURX has higher revenues than ALZN: AURX (1.62M) vs ALZN (0).
ALZNAURXALZN / AURX
Capitalization2.45M72.1M3%
EBITDA-4.16M-2.39M174%
Gain YTD-70.69010.000-707%
P/E RatioN/AN/A-
Revenue01.62M-
Total Cash3.36M55.7K6,029%
Total Debt301K148K203%
FUNDAMENTALS RATINGS
AURX: Fundamental Ratings
AURX
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
71
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALZNAURX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
ALZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AURX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HIPO29.141.21
+4.33%
Hippo Holdings
LGCY11.130.38
+3.53%
Legacy Education Inc.
HBI4.64-0.02
-0.43%
Hanesbrands
OTEX28.87-1.32
-4.37%
Open Text Corp
VRCA0.82-0.04
-4.98%
Verrica Pharmaceuticals

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+3.73%
SRPT - ALZN
49%
Loosely correlated
+1.79%
VRAX - ALZN
43%
Loosely correlated
+6.60%
SNSE - ALZN
41%
Loosely correlated
+1.33%
BPMUF - ALZN
36%
Loosely correlated
N/A
SILO - ALZN
33%
Loosely correlated
+3.23%
More

AURX and

Correlation & Price change

A.I.dvisor tells us that AURX and ALZN have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AURX and ALZN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURX
1D Price
Change %
AURX100%
N/A
ALZN - AURX
30%
Poorly correlated
+3.73%
VRAX - AURX
27%
Poorly correlated
+6.60%
NCNA - AURX
26%
Poorly correlated
+8.45%
FENC - AURX
23%
Poorly correlated
+2.18%
QNCX - AURX
22%
Poorly correlated
+6.21%
More